Randall A. Oyer, MD, discusses the importance of the ACCC community during the unprecedented coronavirus disease 2019 pandemic.
Randall A. Oyer, MD, medical director at the Ann B. Barshinger Cancer Institute of Penn Medicine Lancaster General in Pennsylvania, and current president of the Association of Community Cancer Centers (ACCC), discusses the importance of the ACCC community during the unprecedented coronavirus disease 2019 (COVID-19) pandemic.
The pandemic crystalized the importance of community, at home, in the professional setting, and the bigger community known as ACCC, says Oyer. When something unknown happens, we look for precedent, but there was none for this scenario. Members leaned on each other for support, however, during these new and challenging times.
Colleagues within the ACCC community who were at the forefront of the pandemic in areas such as Seattle and New York were able to share their experiences with the community to show what they have done, what they have tried, and what they have learned, Oyer says. Whether physicians interact via programs, blogs, written material, or during physical meetings, physicians in the ACCC community are readily available to help each other in times of need, which is what Oyer believes the community is about.
Brain Cancer Awareness Month: Challenges and Innovations in Treatment
May 13th 2024In an interview with Targeted Oncology for Brain Cancer Awareness Month, Theodore Schwartz, MD, discussed the challenges of targeting brain tumors, emerging therapies, and strategies to overcome the blood-brain barrier.
Read More
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More